Literature DB >> 25836963

A new path forward: the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM).

Warren Casey1, Abigail Jacobs2, Elizabeth Maull3, Joanna Matheson4, Carol Clarke5, Anna Lowit4.   

Abstract

In 2000, the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) was congressionally established, with representatives from Federal regulatory and research agencies that require, use, generate, or disseminate toxicologic and safety testing information. For over 15 y, ICCVAM and the National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) have worked together to promote the development, validation, and regulatory acceptance of test methods that replace, reduce, or refine the use of animals in regulatory testing. In 2013, both NICEATM and ICCVAM underwent major changes to their operating paradigms, to increase the speed and efficiency of regulatory approval and industry adoption of 3Rs testing methods within the United States and internationally. Accordingly, increased emphasis has been placed on international activities, primarily through interaction with the Organization for Economic Cooperation and Development and participation in the International Cooperation on Alternative Test Methods. In addition, ICCVAM has committed to increasing public awareness of and transparency about federal agencies' 3R activities and to fostering interactions with stakeholders. Finally, although it continues to support ICCVAM, NICEATM's work now includes validation support for Tox21, a collaboration aimed at identifying in vitro methods and computational approaches for testing chemicals to better understand and predict hazards to humans and the environment. The combination of more efficient operating paradigms, increased international collaboration, improved communication and interaction with stakeholders, and active participation in Tox21 likely will substantially increase the number of 3Rs methods developed and used in the United States and internationally.

Entities:  

Mesh:

Year:  2015        PMID: 25836963      PMCID: PMC4382621     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  1 in total

1.  15 years out: reinventing ICCVAM.

Authors:  Linda S Birnbaum
Journal:  Environ Health Perspect       Date:  2013-02       Impact factor: 9.031

  1 in total
  11 in total

Review 1.  Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies.

Authors:  Judy Strickland; Amy J Clippinger; Jeffrey Brown; David Allen; Abigail Jacobs; Joanna Matheson; Anna Lowit; Emily N Reinke; Mark S Johnson; Michael J Quinn; David Mattie; Suzanne C Fitzpatrick; Surender Ahir; Nicole Kleinstreuer; Warren Casey
Journal:  Regul Toxicol Pharmacol       Date:  2018-02-03       Impact factor: 3.271

2.  Special issue: global 3Rs efforts - making progress and gaining momentum.

Authors:  Leticia V Medina; Joachim Coenen; Michael D Kastello
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

Review 3.  In vitro to in vivo extrapolation for high throughput prioritization and decision making.

Authors:  Shannon M Bell; Xiaoqing Chang; John F Wambaugh; David G Allen; Mike Bartels; Kim L R Brouwer; Warren M Casey; Neepa Choksi; Stephen S Ferguson; Grazyna Fraczkiewicz; Annie M Jarabek; Alice Ke; Annie Lumen; Scott G Lynn; Alicia Paini; Paul S Price; Caroline Ring; Ted W Simon; Nisha S Sipes; Catherine S Sprankle; Judy Strickland; John Troutman; Barbara A Wetmore; Nicole C Kleinstreuer
Journal:  Toxicol In Vitro       Date:  2017-12-05       Impact factor: 3.500

Review 4.  IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making.

Authors:  Xiaoqing Chang; Yu-Mei Tan; David G Allen; Shannon Bell; Paul C Brown; Lauren Browning; Patricia Ceger; Jeffery Gearhart; Pertti J Hakkinen; Shruti V Kabadi; Nicole C Kleinstreuer; Annie Lumen; Joanna Matheson; Alicia Paini; Heather A Pangburn; Elijah J Petersen; Emily N Reinke; Alexandre J S Ribeiro; Nisha Sipes; Lisa M Sweeney; John F Wambaugh; Ronald Wange; Barbara A Wetmore; Moiz Mumtaz
Journal:  Toxics       Date:  2022-05-01

5.  Commemorating Toxicology at the National Institute of Environmental Health Sciences on the Occasion of Its 50th Anniversary.

Authors:  John R Bucher; Linda S Birnbaum
Journal:  Environ Health Perspect       Date:  2016-11-01       Impact factor: 9.031

6.  An Explainable Supervised Machine Learning Model for Predicting Respiratory Toxicity of Chemicals Using Optimal Molecular Descriptors.

Authors:  Keerthana Jaganathan; Hilal Tayara; Kil To Chong
Journal:  Pharmaceutics       Date:  2022-04-11       Impact factor: 6.525

Review 7.  The Next Generation of Risk Assessment Multi-Year Study-Highlights of Findings, Applications to Risk Assessment, and Future Directions.

Authors:  Ila Cote; Melvin E Andersen; Gerald T Ankley; Stanley Barone; Linda S Birnbaum; Kim Boekelheide; Frederic Y Bois; Lyle D Burgoon; Weihsueh A Chiu; Douglas Crawford-Brown; Kevin M Crofton; Michael DeVito; Robert B Devlin; Stephen W Edwards; Kathryn Z Guyton; Dale Hattis; Richard S Judson; Derek Knight; Daniel Krewski; Jason Lambert; Elizabeth Anne Maull; Donna Mendrick; Gregory M Paoli; Chirag Jagdish Patel; Edward J Perkins; Gerald Poje; Christopher J Portier; Ivan Rusyn; Paul A Schulte; Anton Simeonov; Martyn T Smith; Kristina A Thayer; Russell S Thomas; Reuben Thomas; Raymond R Tice; John J Vandenberg; Daniel L Villeneuve; Scott Wesselkamper; Maurice Whelan; Christine Whittaker; Ronald White; Menghang Xia; Carole Yauk; Lauren Zeise; Jay Zhao; Robert S DeWoskin
Journal:  Environ Health Perspect       Date:  2016-04-19       Impact factor: 9.031

Review 8.  The C. elegans model in toxicity testing.

Authors:  Piper Reid Hunt
Journal:  J Appl Toxicol       Date:  2016-07-22       Impact factor: 3.446

9.  Counting Caenorhabditis elegans: Protocol Optimization and Applications for Population Growth and Toxicity Studies in Liquid Medium.

Authors:  Leona D Scanlan; Steven P Lund; Sanem Hosbas Coskun; Shannon K Hanna; Monique E Johnson; Christopher M Sims; Karina Brignoni; Patricia Lapasset; Elijah J Petersen; John T Elliott; Bryant C Nelson
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

Review 10.  Caenorhabditis elegans as a Useful Model for Studying Aging Mutations.

Authors:  Siwen Zhang; Fei Li; Tong Zhou; Guixia Wang; Zhuo Li
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-05       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.